John Joseph Sninsky
First SEC filing: Jan. 30, 2018 · Latest: Jan. 30, 2018
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2018 | CDNA | F | 805 | $6.25 | $5,031 | 22,309 Direct | -3.48% | Disposed | 974.4% (price as of 2026-10-02) |
| Jan. 22, 2018 | CDNA | F | 886 | $6.29 | $5,573 | 23,114 Direct | -3.69% | Disposed | 967.6% (price as of 2026-10-02) |
| Sept. 1, 2017 | CDNA | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2017 | CDNA | A | 27,000 | · | · | 27,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2017 | CDNA | A | 10,000 | · | · | 24,000 Direct | +71.43% | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2016 | CDNA | A | 33,000 | · | · | 33,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2016 | CDNA | A | 11,000 | · | · | 14,000 Direct | +366.67% | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2015 | CDNA | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 1, 2017 | CDNA | Employee Stock Option (right to buy) | Common Stock | $2.80 | Sept. 1, 2027 | 10,000 | Acquired |
| Feb. 17, 2017 | CDNA | Employee Stock Option (right to buy) | Common Stock | $2.30 | Feb. 17, 2027 | 27,000 | Acquired |
| Jan. 22, 2016 | CDNA | Employee Stock Option (right to buy) | Common Stock | $5.27 | Jan. 22, 2026 | 33,000 | Acquired |
| Jan. 23, 2015 | CDNA | Option to Purchase Common Stock | Common Stock | $6.87 | Jan. 23, 2025 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $327,033 | · | · | · | $125,766 | · | $6,522 | $662,615 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.